- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
INDGN
NSI
Week ended 07 Aug 2026
Weekly Investor Report
INDEGENE LIMITED · Healthcare · Health Information Services
Latest close
554.5 INR
7.6%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 11.9% above the Trend Line and sits at 76.8% of its 52-week range. The latest completed week returned 7.6%, after a 9.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 58/100.
Setup score
64
out of 100
Latest Close
554.5 INR
7 Aug 2026
1W Return
7.6%
latest completed week
4W Return
9.3%
short-term follow-through
12W Return
7.4%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
6.3x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 39.34% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.6%
Latest completed week; four-week move 9.3%.
Indicator stack
37/47
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.34%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
58/100
19 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 11.9% above the Trend Line and sits at 76.8% of its 52-week range. The latest completed week returned 7.6%, after a 9.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 6.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4812-week average 0.41
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 9.3% over four weeks, 7.4% over 12 weeks, and -2.9% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.18Latest activity-pressure read.
Pressure change-71.8%Four-week change in activity pressure.
Leadership8.24Latest relative-leadership reading.
RS change4662.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength46/100Blend of value, momentum, and quality. Underlying universe rank 55; rank 1 is best.
Value38/100Relative valuation strength. Underlying universe rank 63; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum35/100Medium-term price momentum. Underlying universe rank 66; rank 1 is best.
Growth65/100Revenue and earnings growth. Underlying universe rank 36; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework58/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 32.0x Price divided by trailing earnings.
- Price / sales
- 3.9x Market value relative to trailing revenue.
- EV / EBITDA
- 19.3x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 14.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 17.5% Free cash flow generated from revenue.
- Return on invested capital
- 12.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 23.6% Latest one-year revenue growth.
- EPS growth
- -1.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 47.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.4% Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment58/100
Weighted news tone is neutral across 19 relevant articles.
8 positive · 10 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.1%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+7.6%Week of 7 Aug.
Worst week-7.5%Week of 6 Mar.
Latest week+7.6%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains11
Flat weeks0
Modest losses8
Sharp losses2
Recent vol3.4%13-week weekly-return volatility.
Base vol3.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.3% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank15 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Health Information Services
4-week rank1 / 4
Group average-1.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD100.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape58/100
Trend, activity pressure, participation, and risk combine to a 58/100 tape read.
Indicator analysis65/100Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 8/12.
Activity pressure 0.48; No reversal markers Next-Week ExpectancyNegative 39.34%Next-week expectancy is negative with a 39.34% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors51/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 74; Small Cap Core rank 64 SVQF58/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 661.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is neutral across 19 relevant articles.
Block Deals: Brighton Park Capital exits Indegene for Rs 1,105 crore Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 554.5 INR | 7.6% | 495.4 INR | 558.5 INR | 0.18 | 8.24 | 8.0M | On |
| 31 Jul 2026 | 515.2 INR | 5.0% | 493.9 INR | 558.6 INR | 0.15 | 1.26 | 2.2M | On |
| 24 Jul 2026 | 490.5 INR | -3.6% | 494.1 INR | 558.9 INR | 0.19 | -1.31 | 471.1K | On |
| 17 Jul 2026 | 508.7 INR | 0.3% | 495.1 INR | 559.5 INR | 0.47 | -0.20 | 537.4K | On |
| 10 Jul 2026 | 507.1 INR | 0.2% | 495.9 INR | 560.0 INR | 0.64 | -0.18 | 1.6M | On |
| 3 Jul 2026 | 506.1 INR | -1.9% | 496.5 INR | 560.5 INR | 0.64 | -0.77 | 390.4K | On |
| 26 Jun 2026 | 515.8 INR | -3.1% | 497.5 INR | 560.9 INR | 0.69 | 1.90 | 0 | On |
| 19 Jun 2026 | 532.4 INR | 4.3% | 498.0 INR | 561.4 INR | 0.72 | 5.30 | 237.7K | Off |
| 12 Jun 2026 | 510.4 INR | -2.4% | 497.2 INR | 561.6 INR | 0.72 | 2.53 | 166.6K | Off |
| 5 Jun 2026 | 523.0 INR | 0.3% | 497.2 INR | 562.1 INR | 0.71 | 5.97 | 248.7K | Off |
| 29 May 2026 | 521.5 INR | 2.6% | 497.2 INR | 562.5 INR | 0.76 | 4.79 | 1.0M | Off |
| 22 May 2026 | 508.5 INR | -1.5% | 497.8 INR | 562.8 INR | 0.77 | 1.25 | 647.5K | Off |
| 15 May 2026 | 516.1 INR | -2.6% | 498.9 INR | 563.4 INR | 0.77 | 2.83 | 1.0M | Off |
| 8 May 2026 | 530.0 INR | 6.1% | 499.8 INR | 563.8 INR | 0.72 | 3.04 | 2.6M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.